A previous report35 indicated that in breast cancer cells, SYK was able to downregulate the transcription factor FRA1, which acts as a key EMT switch as well as a drug resistance mediator in cancer.36 We then investigated whether FRA1 was downstream of SYK in our scenario. This evidence concerns the gene FOSL1 and breast cancer.